Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Rituximab Therapeutic Response Versus Conventional Treatment in the Management of Refractory Nephrotic Syndrome

NCT05553496 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05553496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05553496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Rituximab Therapeutic Response Versus Conventional Treatment in the Management of Refractory Nephrotic Syndrome
Lead sponsor
Ain Shams University
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 25, 2022
Completion date
October 1, 2023
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacological action